MediciNova, Inc. (MNOV)
USD 2.15
(0.94%)
USD 2.15
(0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.43 Million | -12.91 Million | -9.38 Million | -10.82 Million | -9.12 Million | -9.11 Million |
| Net Income | -8.57 Million | -14.06 Million | -10.13 Million | -13.85 Million | -12.94 Million | -14.67 Million |
| Depreciation & Amortization | 20.29 Thousand | 17.7 Thousand | 26.14 Thousand | 21.34 Thousand | 23.94 Thousand | 25.88 Thousand |
| Deferred income taxes | 449.37 Thousand | - | 286.00 | -3.44 Million | -3.96 Million | - |
| Stock-based compensation | 710.71 Thousand | 642.52 Thousand | 1.71 Million | 3.17 Million | 4.11 Million | 6.33 Million |
| Change in working capital | 111.98 Thousand | 334.1 Thousand | -1.2 Million | -169.36 Thousand | -319.92 Thousand | -775.35 Thousand |
| Other non-cash items | -151.88 Thousand | 163.19 Thousand | 216.64 Thousand | 3.44 Million | 3.96 Million | -19.86 Thousand |
| Investing Cash Flow | 39.9 Million | -40 Million | -28.73 Thousand | -36.49 Thousand | -11.27 Thousand | 626.32 Thousand |
| Investments in PPE | -21.29 Thousand | -5010.00 | -28.73 Thousand | -36.49 Thousand | -11.27 Thousand | -10.2 Thousand |
| Acquisitions | - | 5.01 Million | - | - | - | 636.52 Thousand |
| Investment purchases | - | -59.87 Million | - | - | - | - |
| Sales/Maturities of investments | 39.92 Million | 19.87 Million | - | - | - | 636.52 Thousand |
| Other Investing Activities | 39.92 Million | -5.01 Million | -28.73 Million | -36.49 Million | -11.27 Million | 636.52 Thousand |
| Financing Cash Flow | 32.46 Billion | 7920.00 | 20.77 Million | 7.1 Million | 10.61 Million | 42.8 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7920.00 | 20.89 Million | 7.29 Million | 10.58 Million | 42.75 Million |
| Other Financing Activities | - | 7.92 | -112.25 Thousand | -192.13 Thousand | 27.32 Thousand | 51 Thousand |
| Accounts receivables | - | - | - | - | - | -111.68 Thousand |
| Accounts payables | 19.23 Thousand | 329.01 Thousand | -1.02 Million | -224.31 Thousand | 194.09 Thousand | -663.67 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 92.74 Thousand | 5090.00 | -181.41 Thousand | 54.95 Thousand | -514.02 Thousand | -111.68 Thousand |
| Cash at beginning of period | 18.5 Million | 71.43 Million | 60.03 Million | 63.79 Million | 62.31 Million | 27.99 Million |
| Cash at end of period | 50.99 Million | 18.5 Million | 71.43 Million | 60.03 Million | 63.79 Million | 62.31 Million |
| Capital Expenditure | -21.29 Thousand | -5010.00 | -28.73 Thousand | -36.49 Thousand | -11.27 Thousand | -10.2 Thousand |
| Effect of forex changes on cash | 17.27 Thousand | -16.8 Thousand | 26.54 Thousand | 1201.00 | -53.00 | 691.00 |
| Net cash flow / Change in cash | 32.49 Million | -52.92 Million | 11.39 Million | -3.75 Million | 1.47 Million | 34.32 Million |
| Free Cash Flow | -7.45 Million | -12.91 Million | -9.41 Million | -10.86 Million | -9.13 Million | -9.12 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 FY | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.62 Million | -2.75 Million | -2.05 Million | -8.57 Million | -723.1 Thousand | -2.87 Million |
| Depreciation & Amortization | 5370.00 | 5350.00 | 5492.00 | 20.29 Thousand | 5703.00 | 4995.00 |
| Deferred income taxes | - | - | 346.49 Thousand | 449.37 Thousand | 371.00 | - |
| Stock-based compensation | 207.45 Thousand | 215.43 Thousand | -237.4 Thousand | 710.71 Thousand | 219.14 Thousand | 325.71 Thousand |
| Change in working capital | -431.75 Thousand | -1.38 Million | 1.74 Million | 111.98 Thousand | -921.22 Thousand | 108.97 Thousand |
| Other non-cash items | 253.89 Thousand | 1.05 Million | -298.09 Thousand | -151.88 Thousand | 47.56 Thousand | 49.12 Thousand |
| Investing Cash Flow | -891.00 | - | 22.00 | 39.9 Million | -2744.00 | -18.57 Thousand |
| Investments in PPE | -891.00 | - | 22.00 | -21.29 Thousand | -2744.00 | -18.57 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 39.88 Billion | 39.92 Million | - | - |
| Other Investing Activities | -891.00 | - | -21.29 Million | 39.92 Million | - | - |
| Financing Cash Flow | - | - | - | 32.46 Billion | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | 1 Million | - | -1 Million | - |
| Accounts payables | 507.00 | -781.34 Thousand | 476.91 Thousand | 19.23 Thousand | -28.79 Thousand | 30.37 Thousand |
| Inventory | - | - | -1 Million | - | 1 Million | - |
| Other working capital | -432.26 Thousand | -602.55 Thousand | 1.26 Million | 92.74 Thousand | -892.42 Thousand | 78.6 Thousand |
| Cash at beginning of period | 47.13 Million | 50.99 Million | 51.5 Million | 18.5 Million | 52.87 Million | 55.25 Million |
| Cash at end of period | 44.33 Million | 47.13 Million | 50.99 Million | 50.99 Million | 51.5 Million | 52.87 Million |
| Capital Expenditure | -891.00 | - | 22.00 | -21.29 Thousand | -2744.00 | -18.57 Thousand |
| Effect of forex changes on cash | 10.84 Thousand | 7605.00 | -8881.00 | 17.27 Thousand | 5383.00 | 18.49 Thousand |
| Net cash flow / Change in cash | -2.8 Million | -3.86 Million | -507.91 Thousand | 32.49 Million | -1.36 Million | -2.38 Million |
| Free Cash Flow | -2.81 Million | -3.86 Million | -499.03 Thousand | -7.45 Million | -1.37 Million | -2.4 Million |
JORFF
PM
2321
IRIS
7438
ULTA